Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-13

FDA Approved: PARICALCITOL — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal's original application for generic paricalcitol (PARICALCITOL), a vitamin D analog used to treat secondary hyperparathyroidism in adults wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paricalcitol (paricalcitol)

Snippet

ORIG AP for PARICALCITOL (PARICALCITOL)